As the respiratory tract is the initial site of viral infection and replication, the levels of IgG and IgA against the RBD in the upper and lower airways are likely critical for SARS-CoV-2 neutralization and could therefore help predict the ability of individuals to neutralize the virus locally in case of reexposure. This evidence concerns the gene CD79A and viral infectious disease.